The impact of Light and Sound therapy on well-being of Healthy adults

Evaluating the Role of Light and Sound Therapy on overall Well-Being of Healthy Adults using self-reported questionnaire and blood biomarkers - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084630

Enrollment

Registered

2025-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Light and Sound Therapy: Light and Sound Therapy is a non-invasive, 20-minute session that exposes the participant to various light frequencies (colors) and sound frequencies. During th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy individuals with no major medical conditions or comorbidities. 2. No history of neurological or psychiatric conditions, such as depression, anxiety, or schizophrenia. 3. Individuals who are not on any medication (e.g., sedatives, antidepressants, or hormonal therapies) 4. Individuals who are not currently pregnant or breastfeeding. 5. Able and willing to provide informed consent and adhere to study procedures.

Exclusion criteria

Exclusion criteria: 1. Individuals with a history of major sleep disorders (e.g., insomnia, sleep apnea). 2. Individuals with a history of neurological or psychiatric disorders. 3. Pregnant or breastfeeding women. 4. Individuals currently undergoing other forms of stress-reducing therapies (e.g., regular counseling or medication). 5. Individuals taking any other therapy or treatment for sleep improvement 6. Individuals with diabetes, hypertension or dyslipidemia

Design outcomes

Primary

Measure	Time frame
Changes in overall well-being scores, stress scores or Sleep scoresTimepoint: Baseline and end of the six sessions (2 weeks)	—

Secondary

Measure	Time frame
Changes in blood biomarkers (TSH profile, cortisol levels, liver and kidney function tests, ACTH and insulin levels)Timepoint: Baseline and Six weeks(5 sessions/week);Changes in Heart Rate variabilityTimepoint: Baseline and Six weeks (5 sessions/week);Changes in pain tolerance using visual analouge scaleTimepoint: Baseline and six weeks (5 sessions/week)	—

Countries

India

Contacts

Public ContactSaumya Subramanian

Sri Sri Institute for Advanced Research

saumya.subramanian@ssiar.org9916127792

Outcome results